Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis

The aim of this study was to evaluate periostin expression measured immunohistochemically in patients with non-small cell lung cancer (NSCLC) and to determine its association with clinical features, prognosis, angiogenesis, and lymphangiogenesis. We investigated periostin expression in a series of 8...

Full description

Saved in:
Bibliographic Details
Published in:The International journal of biological markers 2008-07, Vol.23 (3), p.182-186
Main Authors: TAKANAMI, I, ABIKO, T, KOIZUMI, S
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Analytical, structural and metabolic biochemistry
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - metabolism
Cell Adhesion Molecules - biosynthesis
Female
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry - methods
Investigative techniques, diagnostic techniques (general aspects)
Lung Neoplasms - metabolism
Lymphangiogenesis
Male
Medical sciences
Middle Aged
Neovascularization, Pathologic
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753
cites cdi_FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753
container_end_page 186
container_issue 3
container_start_page 182
container_title The International journal of biological markers
container_volume 23
creator TAKANAMI, I
ABIKO, T
KOIZUMI, S
description The aim of this study was to evaluate periostin expression measured immunohistochemically in patients with non-small cell lung cancer (NSCLC) and to determine its association with clinical features, prognosis, angiogenesis, and lymphangiogenesis. We investigated periostin expression in a series of 88 patients with NSCLC. We also determined whether expression of periostin correlated with microvessel density and lymphatic microvessel density. Periostin was expressed in 42% of 88 patients. Its expression was significantly correlated with tumor size, lymph node metastasis, disease stage, and lymphatic invasion (p=0.0128, 0.0015, 0.0310 and 0.0273, respectively). There also was a significant relation between periostin expression and microvessel density and lymphatic microvessel density (all p
doi_str_mv 10.1177/172460080802300308
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69706566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69706566</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753</originalsourceid><addsrcrecordid>eNplkEFrGzEQhUVIiV23f6CHokty23a00kra3oJxmoChl_a8aGWtrbIrbTVrEv_7yLVJAmHEDHp885AeIV8YfGNMqe9MlUIC6FwlB-CgL8j8KBZH9ZLMgde8kKyqZuQj4l-AkoGSV2TGdC1qJao5OayexuQQfQw0dnR0yUecfKD5jGbyLkxIH_20oyGGAgfT99S63Pp92FJrgnWJ_qA2puT6zGeb_7QJWx-3Ljj0mC8b2h-GcfdW_UQ-dKZH9_k8F-TP3er38r5Y__r5sLxdF5ZDNRXC2paBrEV-eWs517prndYbEKUTttJGqc5KDlaVJWyM7ExbM95pK5QVXFV8QW5OvmOK__YOp2bwePyCCS7usZG1AllJmcHyBNoUEZPrmjH5waRDw6A5Bt68DzwvfT2779vBbV5Xzgln4PoMGLSm71KOzOMLV4IWinHNnwFIWooT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69706566</pqid></control><display><type>article</type><title>Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis</title><source>SAGE Open Access Journals</source><creator>TAKANAMI, I ; ABIKO, T ; KOIZUMI, S</creator><creatorcontrib>TAKANAMI, I ; ABIKO, T ; KOIZUMI, S</creatorcontrib><description>The aim of this study was to evaluate periostin expression measured immunohistochemically in patients with non-small cell lung cancer (NSCLC) and to determine its association with clinical features, prognosis, angiogenesis, and lymphangiogenesis. We investigated periostin expression in a series of 88 patients with NSCLC. We also determined whether expression of periostin correlated with microvessel density and lymphatic microvessel density. Periostin was expressed in 42% of 88 patients. Its expression was significantly correlated with tumor size, lymph node metastasis, disease stage, and lymphatic invasion (p=0.0128, 0.0015, 0.0310 and 0.0273, respectively). There also was a significant relation between periostin expression and microvessel density and lymphatic microvessel density (all p&lt;0.0001). Five-year survival rates were better in patients with negative periostin expression than in those with positive periostin expression (p=0.0044). Periostin expression was not significant in a multivariate additive model. Our findings show that periostin correlates with increased tumor progression and a worse prognosis in NSCLC, as well as with angiogenesis and lymphangiogenesis.</description><identifier>ISSN: 0393-6155</identifier><identifier>EISSN: 1724-6008</identifier><identifier>DOI: 10.1177/172460080802300308</identifier><identifier>PMID: 18949745</identifier><language>eng</language><publisher>Milano: Wichtig</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; Carcinoma, Non-Small-Cell Lung - metabolism ; Cell Adhesion Molecules - biosynthesis ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Neoplastic ; Humans ; Immunohistochemistry - methods ; Investigative techniques, diagnostic techniques (general aspects) ; Lung Neoplasms - metabolism ; Lymphangiogenesis ; Male ; Medical sciences ; Middle Aged ; Neovascularization, Pathologic ; Treatment Outcome</subject><ispartof>The International journal of biological markers, 2008-07, Vol.23 (3), p.182-186</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753</citedby><cites>FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20847138$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18949745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TAKANAMI, I</creatorcontrib><creatorcontrib>ABIKO, T</creatorcontrib><creatorcontrib>KOIZUMI, S</creatorcontrib><title>Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis</title><title>The International journal of biological markers</title><addtitle>Int J Biol Markers</addtitle><description>The aim of this study was to evaluate periostin expression measured immunohistochemically in patients with non-small cell lung cancer (NSCLC) and to determine its association with clinical features, prognosis, angiogenesis, and lymphangiogenesis. We investigated periostin expression in a series of 88 patients with NSCLC. We also determined whether expression of periostin correlated with microvessel density and lymphatic microvessel density. Periostin was expressed in 42% of 88 patients. Its expression was significantly correlated with tumor size, lymph node metastasis, disease stage, and lymphatic invasion (p=0.0128, 0.0015, 0.0310 and 0.0273, respectively). There also was a significant relation between periostin expression and microvessel density and lymphatic microvessel density (all p&lt;0.0001). Five-year survival rates were better in patients with negative periostin expression than in those with positive periostin expression (p=0.0044). Periostin expression was not significant in a multivariate additive model. Our findings show that periostin correlates with increased tumor progression and a worse prognosis in NSCLC, as well as with angiogenesis and lymphangiogenesis.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Cell Adhesion Molecules - biosynthesis</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Immunohistochemistry - methods</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lymphangiogenesis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neovascularization, Pathologic</subject><subject>Treatment Outcome</subject><issn>0393-6155</issn><issn>1724-6008</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNplkEFrGzEQhUVIiV23f6CHokty23a00kra3oJxmoChl_a8aGWtrbIrbTVrEv_7yLVJAmHEDHp885AeIV8YfGNMqe9MlUIC6FwlB-CgL8j8KBZH9ZLMgde8kKyqZuQj4l-AkoGSV2TGdC1qJao5OayexuQQfQw0dnR0yUecfKD5jGbyLkxIH_20oyGGAgfT99S63Pp92FJrgnWJ_qA2puT6zGeb_7QJWx-3Ljj0mC8b2h-GcfdW_UQ-dKZH9_k8F-TP3er38r5Y__r5sLxdF5ZDNRXC2paBrEV-eWs517prndYbEKUTttJGqc5KDlaVJWyM7ExbM95pK5QVXFV8QW5OvmOK__YOp2bwePyCCS7usZG1AllJmcHyBNoUEZPrmjH5waRDw6A5Bt68DzwvfT2779vBbV5Xzgln4PoMGLSm71KOzOMLV4IWinHNnwFIWooT</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>TAKANAMI, I</creator><creator>ABIKO, T</creator><creator>KOIZUMI, S</creator><general>Wichtig</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080701</creationdate><title>Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis</title><author>TAKANAMI, I ; ABIKO, T ; KOIZUMI, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Cell Adhesion Molecules - biosynthesis</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Immunohistochemistry - methods</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lymphangiogenesis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neovascularization, Pathologic</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TAKANAMI, I</creatorcontrib><creatorcontrib>ABIKO, T</creatorcontrib><creatorcontrib>KOIZUMI, S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The International journal of biological markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TAKANAMI, I</au><au>ABIKO, T</au><au>KOIZUMI, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis</atitle><jtitle>The International journal of biological markers</jtitle><addtitle>Int J Biol Markers</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>23</volume><issue>3</issue><spage>182</spage><epage>186</epage><pages>182-186</pages><issn>0393-6155</issn><eissn>1724-6008</eissn><abstract>The aim of this study was to evaluate periostin expression measured immunohistochemically in patients with non-small cell lung cancer (NSCLC) and to determine its association with clinical features, prognosis, angiogenesis, and lymphangiogenesis. We investigated periostin expression in a series of 88 patients with NSCLC. We also determined whether expression of periostin correlated with microvessel density and lymphatic microvessel density. Periostin was expressed in 42% of 88 patients. Its expression was significantly correlated with tumor size, lymph node metastasis, disease stage, and lymphatic invasion (p=0.0128, 0.0015, 0.0310 and 0.0273, respectively). There also was a significant relation between periostin expression and microvessel density and lymphatic microvessel density (all p&lt;0.0001). Five-year survival rates were better in patients with negative periostin expression than in those with positive periostin expression (p=0.0044). Periostin expression was not significant in a multivariate additive model. Our findings show that periostin correlates with increased tumor progression and a worse prognosis in NSCLC, as well as with angiogenesis and lymphangiogenesis.</abstract><cop>Milano</cop><pub>Wichtig</pub><pmid>18949745</pmid><doi>10.1177/172460080802300308</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0393-6155
ispartof The International journal of biological markers, 2008-07, Vol.23 (3), p.182-186
issn 0393-6155
1724-6008
language eng
recordid cdi_proquest_miscellaneous_69706566
source SAGE Open Access Journals
subjects Adult
Aged
Aged, 80 and over
Analytical, structural and metabolic biochemistry
Biological and medical sciences
Carcinoma, Non-Small-Cell Lung - metabolism
Cell Adhesion Molecules - biosynthesis
Female
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry - methods
Investigative techniques, diagnostic techniques (general aspects)
Lung Neoplasms - metabolism
Lymphangiogenesis
Male
Medical sciences
Middle Aged
Neovascularization, Pathologic
Treatment Outcome
title Expression of periostin in patients with non-small cell lung cancer : correlation with angiogenesis and lymphangiogenesis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A01%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20periostin%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20:%20correlation%20with%20angiogenesis%20and%20lymphangiogenesis&rft.jtitle=The%20International%20journal%20of%20biological%20markers&rft.au=TAKANAMI,%20I&rft.date=2008-07-01&rft.volume=23&rft.issue=3&rft.spage=182&rft.epage=186&rft.pages=182-186&rft.issn=0393-6155&rft.eissn=1724-6008&rft_id=info:doi/10.1177/172460080802300308&rft_dat=%3Cproquest_cross%3E69706566%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c305t-4ccb10694076bc3388fbe88d042e4c58a77fc630c7220da6fab913f8c47c43753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69706566&rft_id=info:pmid/18949745&rfr_iscdi=true